UPMC HEART AND VASCULAR INSTITUTE | UNIVERSITY OF PITTSBURGH | FIND PEOPLE
VMI
 


Vascular Medicine Institute
University of Pittsburgh
BST E1240
200 Lothrop Street
Pittsburgh, PA 15261
Phone: 412-383-5853
Fax: 412-648-5980

Timothy C. Wong, MD, MS

 

Tim Wong MD

 

Timothy Wong, MD

Assistant Professor of Medicine,
Division of Cardiology

Director, UPMC Hypertrophic Cardiomyopathy Center

UPMC Heart and Vascular Institute
UPMC Presbyterian, A344
200 Lothrop Street
Pittsburgh, PA 15213

Phone: 412-648-6598
Email: wongtc@upmc.edu

Assistant: Shelly Ossman
ossmanmr@upmc.edu | 412-648-6598

UPMC Profile

   

Bio

Dr. Wong focuses his clinical and research efforts on multimodality cardiovascular imaging, combining his background in echocardiography and nuclear cardiology with advanced training in cardiac MRI. His imaging skillset was instrumental in helping establish the UPMC Hypertrophic Cardiomyopathy Center at UPMC Presbyterian - one of approximately 30 such centers in the United States - where patients receive expert care from a multi-disciplinary team. Dr. Wong continues to maintain a general cardiology practice as well at the Magee Women's Hospital Heart Center. His research topics include the comparative effectiveness of cardiovascular imaging modalities, as well as the role of a novel cardiac MRI biomarker of diffuse myocardial fibrosis in cardiovascular diseases, including hypertrophic cardiomyopathy. His work has been published in major scientific journals, including Circulation and the European Heart Journal. He also participates as a site investigator in many multi-center research protocols, while serving as a scientific reviewer for numerous journals, a national grant review study section, and imaging society working groups.

Clinical and Research Interests

Comparative effectiveness of cardiovascular imaging

Cardiovascular magnetic resonance, echocardiography, nuclear perfusion imaging

T1 maping techniques for myocardial extracellular matrix expansion assessment

Hypertrophic cardiomyopathy

Health outcomes


Education and Training

BS, Yale University, 1998

MD, New York University School of Medicine, 2002

MS, University of Pittsburgh Institute for Clinical Research Education, 2013

Internal Medicine, New York University School of Medicine, Bellevue Hospital, 2005

Chief Medical Resident, New York University School of Medicine, 2006

Cardiovascular Disease, University of Pittsburgh Medical Center, UPMC Presbyterian, 2009

Advanced Cardiac Imaging - Cardiac MRI, University of Pittsburgh MEdical Center, UPMC Prebyterian, 2010


Recent Grants

Cardiovascular Magnetic Resonance Assessment of Diffuse Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Role: Principal Investigator
Funding Agencies: American Heart Association/Children's Cardiomyopathy Foundation
Start/End: 2014/2017


Publications

Wong TC. (2014) Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy. Curr Cardiovasc Imaging Rep. 7:9267. PMID: 24719675. PMCID: PMC3973947.

Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, Kellman P, Cook SC, Schwartman DS, Simon MA, Mulukutla SR, Schelbert EB. (2013). Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 15:6. PMID: 23324403. PMCID: PMC3599652.

Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB. (2012). Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 126(10):1206-16. PMID: 22851543. PMCID: PMC3464491.

Kuller LH, Wong TC. (2014). Coronary artery disease. Detection of ischaemic heart disease in symptomatic women. Nat Rev Cardiol. 11(9):505-6. PMID: 25072911.

Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG, Wong TC. (2011). Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson. 13:16. PMID: 21375743. PMCID: PMC3059279.

Piehler KM, Wong TC, Puntil KS, Zareba KM, Lin K, Harris DM, Deible CR, Lacomis JM, Czeyda-Pommersheim F, Cook SC, Kellman P, Schelbert EB. (2013). Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients. Circ Cardiovasc Imaging. 6(3):423-32. PMID: 23599309. PMCID: PMC4066466.

Wong TC, Piehler KM, Zareba KM, Lin K, Phrampus A, Patel A, Moon JC, Ugander M, Valeti U, Holtz JE, Fu B, Chang CC, Mathier M, Kellman P, Butler J, Gheorghiade M, Schelbert EB. (2013). Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure. J Am Heart Assoc. 2(6):e000416. PMID: 24249712. PMCID: PMC3886781.

Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Siman MA, Shroff SG, Kuller LH, Schelbert EB. (2014). Myocardial extracellular volume fraction quantified by cadiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 35(10):657-64. PMID: 23756336. PMCID: PMC3945798.

See Pub Med for more of Dr. Wong's publications.